Penumbra Wins FDA Clearance For Lightning CAVT Technology To Treat Deep Vein Thrombosis, Backed By BOLT-DVT Trial Results

Penumbra, Inc. has received FDA clearance for its Lightning computer assisted vacuum thrombectomy (CAVT) technology to treat deep vein thrombosis (DVT). This approval is based on positive results from the BOLT-DVT trial, which confirmed the safety and efficacy of CAVT for DVT treatment. The company is recognized as a leader in thrombectomy solutions.